X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
recombinant human erythropoietin (742) 742
humans (549) 549
science & technology (435) 435
life sciences & biomedicine (424) 424
male (330) 330
erythropoietin - therapeutic use (311) 311
female (293) 293
recombinant proteins (247) 247
middle aged (217) 217
adult (187) 187
aged (163) 163
anemia - drug therapy (153) 153
erythropoietin - administration & dosage (147) 147
anemia - etiology (143) 143
recombinant proteins - therapeutic use (142) 142
anemia (136) 136
erythropoietin (125) 125
urology & nephrology (119) 119
animals (114) 114
erythropoietin - pharmacology (107) 107
renal dialysis (98) 98
hematocrit (87) 87
kidney failure, chronic - complications (87) 87
kidney failure, chronic - therapy (84) 84
hemodialysis (77) 77
erythropoietin - adverse effects (76) 76
hematology (69) 69
anemia - blood (67) 67
anemia - therapy (65) 65
treatment outcome (64) 64
pharmacology & pharmacy (58) 58
recombinant proteins - administration & dosage (56) 56
recombinant proteins - pharmacology (56) 56
hemoglobins - analysis (55) 55
renal dialysis - adverse effects (55) 55
darbepoetin alfa (52) 52
rats (49) 49
anaemia (47) 47
time factors (45) 45
adolescent (44) 44
blood transfusion (44) 44
kidney failure, chronic - blood (44) 44
aged, 80 and over (42) 42
chronic renal failure (42) 42
erythropoietin - blood (39) 39
injections, subcutaneous (39) 39
original paper (39) 39
epoetin alfa (37) 37
prospective studies (35) 35
quality of life (35) 35
erythropoietin - pharmacokinetics (34) 34
oncology (34) 34
renal anemia (34) 34
dose-response relationship, drug (33) 33
chemistry (32) 32
hemoglobins - metabolism (32) 32
hemoglobin (31) 31
mice (31) 31
physical sciences (31) 31
erythropoietin - analogs & derivatives (30) 30
general & internal medicine (30) 30
recombinant-human-erythropoietin (30) 30
hypertension (29) 29
hematinics - therapeutic use (28) 28
injections, intravenous (28) 28
transplantation (28) 28
erythropoiesis (27) 27
retrospective studies (27) 27
medicine, general & internal (26) 26
biochemistry & molecular biology (25) 25
ferritins - blood (25) 25
medicine, research & experimental (25) 25
research & experimental medicine (25) 25
analysis (24) 24
chronic kidney disease (24) 24
erythropoietin - chemistry (24) 24
erythropoietin - metabolism (24) 24
autologous blood transfusion (23) 23
blood transfusion, autologous (23) 23
cancer (23) 23
end-stage renal disease (23) 23
erythropoietin - genetics (23) 23
kidney failure, chronic - drug therapy (23) 23
recombinant proteins - adverse effects (23) 23
care and treatment (22) 22
child (22) 22
drug therapy, combination (22) 22
health aspects (22) 22
prognosis (22) 22
erythropoiesis - drug effects (21) 21
proteins (21) 21
rats, sprague-dawley (21) 21
risk factors (21) 21
anemia - complications (20) 20
apoptosis (20) 20
blood pressure (20) 20
blood pressure - drug effects (20) 20
epo (20) 20
haemodialysis (20) 20
abridged index medicus (19) 19
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (749) 749
Japanese (116) 116
Chinese (33) 33
Portuguese (13) 13
French (12) 12
Spanish (9) 9
Korean (8) 8
Italian (5) 5
Polish (4) 4
German (3) 3
Czech (2) 2
Dutch (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 11/2009, Volume 361, Issue 21, pp. 2019 - 2032
Anemia is associated with an increased risk of cardiovascular and renal events among patients with type 2 diabetes and chronic kidney disease. This... 
ERYTHROPOIESIS-STIMULATING AGENTS | RANDOMIZED-TRIALS | RISK-FACTOR | ANEMIA CORRECTION | CLINICAL-TRIALS | CARDIOVASCULAR-DISEASE | HEMODIALYSIS-PATIENTS | RECOMBINANT HUMAN ERYTHROPOIETIN | EPOETIN-ALPHA | UMCG Approved | STAGE RENAL-DISEASE | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Erythropoietin - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Erythropoietin - adverse effects | Male | Renal Insufficiency, Chronic - complications | Erythropoietin - analogs & derivatives | Anemia - drug therapy | Stroke - chemically induced | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Anemia - etiology | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Hematinics - therapeutic use | Kaplan-Meier Estimate | Neoplasms - mortality | Hematinics - adverse effects | Renal Insufficiency, Chronic - blood | Kidney Failure, Chronic - epidemiology | Kidney Failure, Chronic - prevention & control | Aged | Darbepoetin alfa | Hemoglobins - analysis | Type 2 diabetes | Complications and side effects | Outcome and process assessment (Health Care) | Drug therapy | Cardiovascular diseases | Risk factors | Hypertension | Hypotheses | Transplants & implants | Patient safety | Kidney diseases | Diabetes | Blood diseases | Index Medicus | Abridged Index Medicus
Journal Article
Transfusion medicine and hemotherapy, ISSN 1660-3818, 2013, Volume 40, Issue 5, pp. 302 - 309
Human erythropoietin (Epo) is a 30.4 kDa glycoprotein hormone composed of a single 165 amino acid residues chain to which four glycans are attached. The... 
Review Article | Erythrocytic progenitors | Hypoxia | Chronic kidney disease | Red blood cells | Recombinant human erythropoietin | Anemia | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Review
Journal Article
Clinical Kidney Journal, ISSN 2048-8505, 2019, Volume 12, Issue 1, pp. 139 - 148
Abstract Background This study evaluated the hemoglobin dose response, other efficacy measures and safety of daprodustat, an orally administered,... 
hemodialysis | chronic kidney disease | daprodustat | recombinant human erythropoietin | anemia | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Complications and side effects | Chronic kidney failure | Anemia | Hemodialysis | Development and progression | Drug therapy | Observations
Journal Article
Journal of neuroinflammation, ISSN 1742-2094, 04/2018, Volume 15, Issue 1, pp. 113 - 113
Journal Article
Neuro-endocrinology letters, ISSN 0172-780X, 10/2018, Volume 39, Issue 4, pp. 310 - 314
OBJECTIVES: Effect of recombinant human erythropoietin (rhEPO) on spontaneous motor activity was tested in young rats after intraperitoneal (i.p.)... 
Water intoxication | Young rats | Cytotoxic edema | Locomotion | Erythropoietin | Recombinant human erythropoietin | Epo | Rhepo | Open field test | Endocrinology & Metabolism | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology
Journal Article
Nephrology, dialysis, transplantation, ISSN 0931-0509, 2002, Volume 17, Issue 11, pp. 39 - 43
Journal Article
Pharmaceutical research, ISSN 0724-8741, 2011, Volume 28, Issue 2, pp. 386 - 393
Journal Article
Kidney international, ISSN 0085-2538, 10/2003, Volume 64, Issue 4, pp. 1514 - 1521
Hemoglobin variability in epoetin-treated hemodialysis patients. Understanding the clinical variability of hemoglobin measurements in epoetin-treated... 
epoetin | hemodialysis | recombinant human erythropoietin | variability | anemia | target | Epoetin | Target | Recombinant human erythropoietin | Anemia | Hemodialysis | Variability | Time Factors | Erythropoietin - therapeutic use | Humans | Middle Aged | Hemoglobins - metabolism | Female | Male | Aged | Retrospective Studies | Recombinant Proteins | Renal Dialysis | Index Medicus
Journal Article
Journal Article